Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
25.2M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
100
-
Shares change
-
-4.11M
-
Total reported value, excl. options
-
$1.00
-
Value change
-
-$2.88M
-
Number of sells
-
-39
-
Price
-
$0.01
Significant Holders of Accelerate Diagnostics, Inc - Common Stock, $0.001 par value per share (AXDX) as of Q2 2025
42 filings reported holding AXDX - Accelerate Diagnostics, Inc - Common Stock, $0.001 par value per share as of Q2 2025.
Accelerate Diagnostics, Inc - Common Stock, $0.001 par value per share (AXDX) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 100 shares
of 25.2M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include BARTLETT & CO. WEALTH MANAGEMENT LLC (100 shares), ALBION FINANCIAL GROUP /UT (0 shares), GRIFFIN ASSET MANAGEMENT, INC. (0 shares), Belpointe Asset Management LLC (0 shares), Ironwood Financial, llc (0 shares), THOMPSON INVESTMENT MANAGEMENT, INC. (0 shares), TOWER TRUST & INVESTMENT Co (0 shares), GHP Investment Advisors, Inc. (0 shares), Plante Moran Financial Advisors, LLC (0 shares), and TCI Wealth Advisors, Inc. (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.